CEFTRIAXONE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Ceftriaxone Sodium patents expire, and when can generic versions of Ceftriaxone Sodium launch?
Ceftriaxone Sodium is a drug marketed by Anda Repository and Hikma and is included in two NDAs.
The generic ingredient in CEFTRIAXONE SODIUM is ceftriaxone sodium. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ceftriaxone Sodium
A generic version of CEFTRIAXONE SODIUM was approved as ceftriaxone sodium by ANDA REPOSITORY on January 20th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFTRIAXONE SODIUM?
- What are the global sales for CEFTRIAXONE SODIUM?
- What is Average Wholesale Price for CEFTRIAXONE SODIUM?
Summary for CEFTRIAXONE SODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 26 |
| Patent Applications: | 2 |
| DailyMed Link: | CEFTRIAXONE SODIUM at DailyMed |
Recent Clinical Trials for CEFTRIAXONE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The George Institute | PHASE3 |
| University of Duhok | N/A |
| Sichuan Provincial People's Hospital | PHASE4 |
Pharmacology for CEFTRIAXONE SODIUM
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFTRIAXONE SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFTRIAXONE SODIUM
US Patents and Regulatory Information for CEFTRIAXONE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anda Repository | CEFTRIAXONE SODIUM | ceftriaxone sodium | INJECTABLE;INJECTION | 091117-001 | Jan 20, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | CEFTRIAXONE SODIUM | ceftriaxone sodium | INJECTABLE;INJECTION | 090701-001 | Oct 4, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
